ClinicalTrials.govpublic full text
Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies
t-cell acute lymphoblastic leukemia, acute lymphoblastic leukemia, in relapse, refractory acute lymphoblastic leukemia, t-cell malignancies, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 854872
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.